COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,170 Articles (22,703 medRxiv, 8,467 bioRxiv)

Most recent first Previous |  Page 162: Articles 1611-1620  | Next

Hyperbaric Oxygen Therapy for Long COVID: 3-Month Follow up Results from a Prospective Registry of 232 patients
van Berkel, J., Lalieu, R. C., Joseph, D. R., Hellemons, M. E., Lansdorp, N. A.
10.1101/2024.09.02.24312948 — Posted: 2024-09-03
Chronic post-COVID neuropsychiatric symptoms (PCNPS) persisting beyond one year from being infected during the Omicron wave
Chau, S. W. H., Chue, T. M., Lam, T. C., Lai, Y. L., Chan, R. N. Y., Wong, P. W., Li, S. X., Liu, Y., Chan, J. W., Chan, P. K.-s., Lai, C. K.-C., Leung, T. W., Wing, Y. K.
10.1101/2024.09.01.24312691 — Posted: 2024-09-03
Global Health Security Index Scores are associated with Covid-19 Pandemic Health and Macroeconomic Outcomes
Boyd, M. J., Baker, M. G. J., Wilson, N.
10.1101/2024.09.02.24312964 — Posted: 2024-09-03
SARS-CoV-2 Mediated Inhibition Of Respiratory Syncytial Virus
Thornhill, E. M., Verhoeven, D.
10.1101/2024.09.02.610835 — Posted: 2024-09-03
A Third COVID-19 Vaccine Dose in Kidney Transplant Recipients Induces Antibody Response to Vaccine and Omicron Variants but Shows Limited Ig Subclass Switching
Lee, J. M., Sachithanandham, J., Lee, J. S., Shapiro, J. R., Li, M., Sitaris, I., Peralta, S. R., Wouters, C., Cox, A. L., Segev, D. L., Durand, C. M., Robien, M., Tobian, A. A. R., Karaba, A. H., Blankson, J. N., Werbel, W. A., Pekosz, A., Klein, S. L.
10.1101/2024.09.01.610689 — Posted: 2024-09-03
Spatial and Temporal Hotspot Analysis of COVID-19 in Toronto
Amoako, A. A., Carabali, M., Ge, E., Fisman, D., Tuite, A.
10.1101/2024.08.30.24312852 — Posted: 2024-08-31
Natural language processing to evaluate texting conversations between patients and healthcare providers during COVID-19 Home-Based Care in Rwanda at scale
Lester, R. T., Manson, M., Semakula, M., Jang, H., Mugabo, H., Magzari, A., Blackmer, J. M., Fattah, F., Niyonsenga, S. P., Rwagasore, E., Ruranga, C., Remera, E., Ngabonziza, J. C. S., Carenini, G., Nsanzimana, S.
10.1101/2024.08.30.24312636 — Posted: 2024-08-31
Understanding the clinical characteristics and timeliness of diagnosis for patients diagnosed with Long COVID: A retrospective observational cohort study from North West London
Prociuk, D., Clarke, J., Smith, N., Milne, R., Lee, C., de Lusignan, S., Mir, G., de Kock, J., Mayer, E., Delaney, B. C., LOCOMOTION Consortium
10.1101/2024.08.30.24312849 — Posted: 2024-08-31
SARS-CoV-2 Delta variant induces severe damages in the nasal cavity from the first day post-infection in the Syrian hamster model.
Fusade-Boyer, M., Gambino, A., Merle-Nguyen, L., Saint-Albin, A., Ando-Grard, O., Boujedli, Y., Huet, H., Ar Gouilh, M., Martin-Latil, S., Klonjkowski, B., Meunier, N., Le Poder, S.
10.1101/2024.08.30.610497 — Posted: 2024-08-30
SARS-CoV-2 nsp16 is regulated by host E3 ubiquitin ligases, UBR5 and MARCHF7
Tian, L., Liu, Z., Gao, W., Zhao, Z., Li, X., Zhang, W., Li, Z.
10.1101/2024.08.30.610469 — Posted: 2024-08-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).